Immunovant (IMVT) Institutional Ownership $14.89 -0.19 (-1.29%) As of 11:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Immunovant (NASDAQ:IMVT)CurrentInstitutional OwnershipPercentage47.08%Number ofInstitutional Buyers(last 12 months)114TotalInstitutional Inflows(last 12 months)$602.25MNumber ofInstitutional Sellers(last 12 months)57TotalInstitutional Outflows(last 12 months)$155.93M Get IMVT Insider Trade Alerts Want to know when executives and insiders are buying or selling Immunovant stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data IMVT Institutional Buying and Selling by Quarter Immunovant Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/27/2025 Squarepoint Ops LLC84,919$1.36M0.0%+714.6%0.049% 8/18/2025 Hudson Bay Capital Management LP92,500$1.48M0.0%-42.8%0.053% 8/15/2025 Tower Research Capital LLC TRC 6,140$98K0.0%+228.9%0.004% 8/15/2025 E Fund Management Co. Ltd.11,854$190K0.0%-8.6%0.007% 8/15/2025 Rafferty Asset Management LLC106,470$1.70M0.0%-23.3%0.061% 8/15/2025 Oxford Asset Management LLP11,717$187K0.1%N/A0.007% 8/15/2025 Perceptive Advisors LLC2,137,890$34.21M3.0%-24.8%1.226% 8/15/2025 LMR Partners LLP25,067$401K0.0%N/A0.014% 8/15/2025 Hudson Bay Capital Management LP92,500$1.48M0.0%-42.8%0.053% 8/15/2025 BNP Paribas Financial Markets298,170$4.77M0.0%+144.3%0.171% Get the Latest News and Ratings for IMVT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immunovant and its competitors with MarketBeat's FREE daily newsletter. 8/15/2025 Balyasny Asset Management L.P.197,569$3.16M0.0%N/A0.113% 8/15/2025 Bank of America Corp DE421,726$6.75M0.0%-10.6%0.242% 8/15/2025 Adage Capital Partners GP L.L.C.463,600$7.42M0.0%+2,086.8%0.266% 8/15/2025 Ameriprise Financial Inc.23,553$377K0.0%N/A0.014% 8/14/2025 Canada Pension Plan Investment Board414,800$6.64M0.0%+127.3%0.238% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.42,641$683K0.0%+4.1%0.024% 8/14/2025 Armistice Capital LLC5,200,000$83.20M1.4%-3.7%2.983% 8/14/2025 TFG Asset Management GP Ltd147,817$2.37M0.4%+12.7%0.085% 8/14/2025 The Manufacturers Life Insurance Company 36,124$578K0.0%+2.6%0.021% 8/14/2025 Squarepoint Ops LLC84,919$1.36M0.0%+714.6%0.049% 8/14/2025 HighVista Strategies LLC182,808$2.93M1.1%+91.1%0.105% 8/13/2025 Jump Financial LLC322,846$5.17M0.1%+60.8%0.185% 8/13/2025 Two Seas Capital LP2,252,772$36.04M0.6%+37.1%1.317% 8/13/2025 Invesco Ltd.66,750$1.07M0.0%+20.7%0.039% 8/13/2025 Tejara Capital Ltd84,394$1.35M0.6%+56.9%0.049% 8/13/2025 Norges Bank687,662$11.00M0.0%N/A0.402% 8/13/2025 Capital Fund Management S.A.55,524$888K0.0%N/A0.032% 8/12/2025 XTX Topco Ltd81,188$1.30M0.1%N/A0.047% 8/12/2025 Ameritas Investment Partners Inc.6,976$112K0.0%+14.9%0.004% 8/12/2025 Rhumbline Advisers101,381$1.62M0.0%+21.3%0.059% 8/12/2025 Legal & General Group Plc77,296$1.24M0.0%+6.9%0.045% 8/12/2025 JPMorgan Chase & Co.478,263$7.65M0.0%-26.7%0.280% 8/12/2025 DNB Asset Management AS12,904$206K0.0%-10.1%0.008% 8/12/2025 Swiss National Bank129,800$2.08M0.0%-1.4%0.076% 8/12/2025 Handelsbanken Fonder AB23,800$381K0.0%+13.9%0.014% 8/8/2025 Creative Planning35,368$566K0.0%+21.2%0.021% 8/8/2025 Police & Firemen s Retirement System of New Jersey16,301$261K0.0%+29.5%0.010% 8/8/2025 Geode Capital Management LLC1,825,602$29.21M0.0%+9.1%1.067% 8/8/2025 Quinn Opportunity Partners LLC51,108$818K0.1%+45.6%0.030% 8/8/2025 KBC Group NV1,807$29K0.0%-49.0%0.001% 3 Dirt-Cheap Stocks You Can’t Afford to Ignore (Ad)Often, investors will overlook stocks just because they're cheap. It's a common thought that a cheap price tag means that something must be wrong with the company. But this couldn't be further from the case in many instances.Get your FREE look at these THREE companies right here.8/7/2025 Profund Advisors LLC22,436$359K0.0%-21.4%0.013% 8/7/2025 Connor Clark & Lunn Investment Management Ltd.448,515$7.18M0.0%+23.1%0.262% 7/28/2025 TD Asset Management Inc192,506$3.08M0.0%+5.5%0.113% 7/24/2025 Aberdeen Group plc844,705$13.52M0.0%+3.1%0.494% 7/23/2025 KLP Kapitalforvaltning AS14,500$232K0.0%-22.5%0.008% 7/21/2025 Mirae Asset Global Investments Co. Ltd.6,603$106K0.0%+11.4%0.004% 7/21/2025 Platinum Investment Management Ltd.195,727$3.13M0.2%+24.7%0.114% 7/16/2025 Banque Pictet & Cie SA125,952$2.02M0.0%-14.5%0.074% 7/11/2025 Farther Finance Advisors LLC2,857$46K0.0%+142,750.0%0.002% 6/18/2025 Voya Investment Management LLC34,069$582K0.0%-5.0%0.020% 5/29/2025 Rhumbline Advisers83,555$1.43M0.0%+3.2%0.049% 5/28/2025 Strs Ohio1,600$27K0.0%N/A0.001% 5/19/2025 UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC140,091$2.39M0.0%-49.8%0.082% 5/16/2025 Woodline Partners LP1,497,869$25.60M0.2%+133.0%0.882% 5/16/2025 Goldman Sachs Group Inc.1,007,700$17.22M0.0%+48.6%0.590% 5/16/2025 Two Seas Capital LP1,642,772$28.08M0.9%+8.7%0.967% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.40,971$708K0.0%+8.9%0.024% 5/16/2025 Granahan Investment Management LLC172,316$2.95M0.1%+15.3%0.101% 5/16/2025 EFG Asset Management North America Corp.130,356$2.23M0.4%+76.2%0.077% 5/16/2025 Adage Capital Partners GP L.L.C.21,200$362K0.0%-92.9%0.012% 5/16/2025 ADAR1 Capital Management LLC968,866$16.56M3.1%+23.0%0.570% 5/15/2025 Redmile Group LLC490,394$8.38M0.8%-14.2%0.289% 5/15/2025 Vestal Point Capital LP350,000$5.98M0.4%+677.8%0.206% 5/15/2025 Baker BROS. Advisors LP5,457,881$93.28M1.1%+219.6%3.213% 5/15/2025 Cubist Systematic Strategies LLC58,122$993K0.0%+438.2%0.034% 5/15/2025 Alpine Global Management LLC2,626,692$44.89M11.9%+21.7%1.546% 5/15/2025 DAFNA Capital Management LLC169,996$2.91M0.8%+57.4%0.100% 5/15/2025 Canada Pension Plan Investment Board182,500$3.12M0.0%+91.7%0.107% 5/15/2025 OMERS ADMINISTRATION Corp48,300$825K0.0%N/A0.028% 5/14/2025 Affinity Asset Advisors LLC430,000$7.35M0.7%+330.0%0.253% 5/14/2025 Rafferty Asset Management LLC138,837$2.37M0.0%+19.0%0.082% 5/14/2025 Jump Financial LLC200,835$3.43M0.0%+54.9%0.118% 5/14/2025 AlphaQuest LLC5,700$97K0.0%+1,510.2%0.003% 5/14/2025 T. Rowe Price Investment Management Inc.5,894,824$100.74M0.1%+15.2%3.470% 5/14/2025 BI Asset Management Fondsmaeglerselskab A S2,181$37K0.0%N/A0.001% 5/14/2025 Wellington Management Group LLP25,030$428K0.0%-4.7%0.015% 5/13/2025 Northern Trust Corp536,622$9.17M0.0%+1.8%0.316% 5/13/2025 Tejara Capital Ltd53,790$919K0.4%N/A0.032% 5/13/2025 Aberdeen Group plc819,477$14.01M0.0%+54.0%0.482% 5/13/2025 Fox Run Management L.L.C.13,428$229K0.0%N/A0.008% 5/13/2025 E Fund Management Co. Ltd.12,975$222K0.0%+57.3%0.008% 5/13/2025 Caitong International Asset Management Co. Ltd3,979$68K0.1%+256.5%0.002% 5/13/2025 HighTower Advisors LLC33,273$569K0.0%-2.2%0.020% 5/12/2025 Knott David M Jr22,443$384K0.2%-75.6%0.013% 5/12/2025 Nuveen LLC233,985$4.00M0.0%N/A0.138% 5/12/2025 Invesco Ltd.55,312$945K0.0%-89.0%0.033% 5/12/2025 Covestor Ltd3,764$64K0.0%+187.5%0.002% 5/12/2025 Connor Clark & Lunn Investment Management Ltd.364,229$6.23M0.0%+54.4%0.214% 5/12/2025 Swiss National Bank131,600$2.25M0.0%+30.6%0.077% 5/9/2025 Headlands Technologies LLC2,961$51K0.0%N/A0.002% 3 Dirt-Cheap Stocks You Can’t Afford to Ignore (Ad)Often, investors will overlook stocks just because they're cheap. It's a common thought that a cheap price tag means that something must be wrong with the company. But this couldn't be further from the case in many instances.Get your FREE look at these THREE companies right here.5/9/2025 Deutsche Bank AG411,509$7.03M0.0%+147.2%0.242% 5/9/2025 Charles Schwab Investment Management Inc.626,612$10.71M0.0%+11.0%0.369% 5/9/2025 Vanguard Group Inc.6,936,859$118.55M0.0%+3.9%4.084% 5/9/2025 ABC Arbitrage SA37,449$640K0.1%+26.4%0.022% 5/9/2025 Privium Fund Management B.V.72,000$1.23M0.3%N/A0.042% 5/7/2025 Zurcher Kantonalbank Zurich Cantonalbank13,044$223K0.0%+66.3%0.008% 5/7/2025 TD Asset Management Inc182,398$3.12M0.0%+19.8%0.107% 5/6/2025 KLP Kapitalforvaltning AS18,700$320K0.0%+73.1%0.011% 5/1/2025 Emerald Advisers LLC9,246$158K0.0%-96.2%0.005% 5/1/2025 Arizona State Retirement System19,468$333K0.0%+31.1%0.011% (Data available from 1/1/2016 forward) IMVT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IMVT shares? During the previous two years, 208 institutional investors and hedge funds held shares of Immunovant. The most heavily invested institutionals were FMR LLC ($324.44M), Deep Track Capital LP ($148.62M), Vanguard Group Inc. ($118.55M), Point72 Asset Management L.P. ($112.36M), T. Rowe Price Investment Management Inc. ($100.74M), Baker BROS. Advisors LP ($93.28M), and State Street Corp ($86.17M).Learn more on Immunovant's institutional investors. What percentage of Immunovant's stock is owned by institutional investors? 47.08% of Immunovant's stock is owned by institutional investors. Learn more on IMVT's institutional investor holdings. Which institutional investors have been buying Immunovant's stock? Of the 175 institutional investors that purchased Immunovant's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($5.11M), Baker BROS. Advisors LP ($4.99M), Armistice Capital LLC ($2.67M), Point72 Asset Management L.P. ($2.67M), T. Rowe Price Investment Management Inc. ($2.56M), Two Seas Capital LP ($2.41M), and Vanguard Group Inc. ($1.69M). How much institutional buying is happening at Immunovant? Institutional investors have bought a total of 27,641,202 shares in the last 24 months. This purchase volume represents approximately $602.25M in transactions. Which of Immunovant's major shareholders have been selling company stock? Of the 57 institutional investors that sold Immunovant's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Woodline Partners LP ($772.25K), Perceptive Advisors LLC ($706.18K), Invesco Ltd. ($538.93K), ADAR1 Capital Management LLC ($354.43K), PFM Health Sciences LP ($349.84K), Rock Springs Capital Management LP ($312.21K), and Price T Rowe Associates Inc. MD ($292.80K). How much institutional selling is happening at Immunovant? Institutional investors have sold a total of 7,053,347 shares in the last 24 months. This volume of shares sold represents approximately $155.93M in transactions. Related Companies SLNO Institutional Ownership BBIO Institutional Ownership VRNA Institutional Ownership ELAN Institutional Ownership BPMC Institutional Ownership ROIV Institutional Ownership GRFS Institutional Ownership LEGN Institutional Ownership RVMD Institutional Ownership RYTM Institutional Ownership This page (NASDAQ:IMVT) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunovant, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunovant With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access